The disparities seen in colorectal cancer screening rates appear to be linked not only to racial/ethnic factors but also geography, according to a study of screening status among Medicare enrollees.
Most adults would pay for lab tests that would show their risks for breast and prostate cancers as well as arthritis and Alzheimer disease, even if the tests were not perfectly accurate and did not have direct treatment consequences.
A novel chemoradiation regimen for the treatment of anal cancer is proven to have fewer significant side effects than conventional therapy.
If the US population ages at the rate predicted by the US Census Bureau and cancer incidence, survival rates, and costs remain stable, in the year 2020 direct cancer care expenditures will reach $157.77 billion in 2010 dollars.
The safety and efficiency of bone marrow transplants may improve due to the discovery of a rare molecule that establishes blood stem cells in their niche within the bone marrow.
KRAS gene mutations are strong predictors of reduced overall and progression-free survival and greater treatment failure in patients with advanced colorectal cancer undergoing anti-EGFR therapy.